Hoppa till innehållet
Global sound
STAT Stitch Deep Dive Podcast Beyond The Bedside

STAT Stitch Deep Dive Podcast Beyond The Bedside

CC Pharm | Amiodarone

· 19 min · Säsong 7

Avsnittsbeskrivning

Amiodarone (Cordarone) Clinical 80/20 Summary
1. Mechanism & Physiological Effects (The 20% Science)

• Multiclass Action: Class III antiarrhythmic (potassium blocker delaying phase 2/3 repolarization and prolonging refractory period). Also exhibits Class I (sodium blockade slowing phase 0), Class II (noncompetitive alpha/beta-blockade), and Class IV (calcium blockade) properties.
• Hemodynamics: Relaxes smooth/cardiac muscle, decreasing peripheral/coronary vascular resistance and afterload, reducing myocardial oxygen demand (MVO2).
2. Clinical Uses & Key Dosing

• Ventricular Arrhythmias (ACLS): For pulseless VF/VT: 300 mg IV/IO push, then 150 mg if refractory.
• Stable VT / Wide-Complex Tachycardia: 150 mg IV over 10 min, then 1 mg/min for 6 hours, then 0.5 mg/min maintenance.
• Atrial Fibrillation/Flutter (Off-Label): Rate control and conversion.
• Oral Dosing: Slow absorption and massive tissue distribution require large loading (800–1600 mg/day for 1–3 weeks) before maintenance of 200–400 mg/day.
3. Critical Toxicities & Warnings (The High-Risk 20%)

• Pulmonary Toxicity: Fatal pneumonitis or alveolar/pulmonary fibrosis (up to 17% incidence; 10% mortality). Monitor baseline and regular PFTs and chest X-rays.
• Hepatotoxicity: Can cause severe liver injury. Monitor transaminases; hold or reduce dose if LFTs exceed 3x upper limit of normal.
• Thyroid Dysfunction: Amiodarone is 37% iodine by weight and blocks T4-to-T3 conversion. Can cause hypo- or hyperthyroidism (thyrotoxicosis). Monitor TSH.
• Cardiotoxicity: Bradycardia, AV blocks, and QT prolongation leading to Torsade de Pointes. Contraindicated in sick sinus syndrome and 2nd/3rd-degree block without a pacemaker.
• Ocular/Dermatologic: Corneal microdeposits (common), photosensitivity, and blue-gray skin discoloration.
4. Nursing & Administration Pearls

• Infusion Safety: Concentrations >2 mg/mL cause severe phlebitis; use a central line for infusions >1 hour. Always use an in-line filter and volumetric pump.
• Incompatibility: Adsorbs to PVC (dosing accounts for this) and leaches toxic DEHP plasticizers from PVC tubing. Use glass or polyolefin containers for infusions >2 hours.
• Pharmacokinetics: Highly lipophilic; volume of distribution is ~70 L/kg. Terminal half-life averages 53 days (range 26–107 days). Effects and interactions (inhibits CYP3A4, CYP2C9, P-gp) persist for months after stopping.
• Client Education: Take consistently with/without food. Report new dyspnea or cough immediately. Wear sunscreen. Follow up for ophthalmic, thyroid, and liver testing.

Webbplats: rss.com

Live, senaste timmen: 8 463 låtar på 3 297 stationer i 130 länder

Upptäck världen genom radion

Fler sätt att upptäcka (9)

Hört något bra? Spara det, eller öppna det direkt i Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
La Z 107.3 FMFortsätt lyssna